Quorum is very excited to offer this new suite of services that will make running these complex and important large clinical studies streamlined and simple.
Seattle, WA (PRWEB) July 22, 2014
Quorum Review IRB, the industry leader in central IRB services, announces a new service for large clinical trials called Quick Step™. The offering went live on July 1, 2014 and is designed to address the research industry’s need for seamless study start-up with a large volume of researcher sites. The service is available for studies planning 50 or more North American investigator sites, as well as related studies with a combined planned North American site count of 80 or more. Qualifying studies may also enroll international sites after the minimum for North America is met.
The Quick Step™ program bundles efficiency features that only an IRB of Quorum’s expertise and size can offer. Quick Step™ includes a study manager that is assigned before IRB submission; five hours of complimentary regulatory consulting from one of Quorum’s six in-house attorneys; facilitated completion of our Central Study Questionnaire (CSQ); identification of potential sites for enrollment; and assisted site outreach. Additionally, for the purpose of site enrollment, Quorum can migrate certain site data from related studies already under Quorum’s oversight, as well as data from other IRB forms for studies being transferred to Quorum.
The first stage in Quick Step™ is the assignment of a Quorum Study Manager (in advance of study submission) to help clients expedite and customize their submission process for review. The Study Manager also helps clients determine how best to use their five hours of complimentary regulatory consulting—perhaps for protocol/consent discussion or international country selection. Quorum can populate the client’s submission forms and ensure they are taking full advantage of all efficiencies and customizations available to them.
Additional opportunities for customization and efficiency include custom document citations, consent form development, recruitment material processing prior to initial Board review, and complimentary tracking of amendment language into the consent form. Quick Step™ customers have access to research sites from Quorum’s Site Directory and assistance in outreach to potential sites. Quorum’s Outreach Program has been particularly successful at enrolling high numbers of Institutional sites with Quorum as the central IRB. Once Quick Step™ studies are in-house they are prioritized, and turnaround times are measured and reported to the respective client.
Quorum’s CEO Cami Gearhart says of the new service, “Quorum is very excited to offer this new suite of services that will make running these complex and important large clinical studies streamlined and simple.”
For more details on Quorum Review’s new Quick Step™ service, visit http://www.quorumreview.com/quickstep.
About Quorum Review IRB
Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of human clinical research since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services include 15 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure Web Portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, international ethics review, a specialized Phase I team, and unique processes for minimal risk research.